Department of Biomedical Engineering, Graeme Clark Institute, University of Melbourne, Parkville, VIC, Australia; Department of Maternal-Fetal Medicine Pregnancy Research Centre, Royal Women's Hospital, Parkville, VIC, Australia.
School of Human Sciences, University of Western Australia, Crawley, Western Australia, Australia.
Acta Biomater. 2024 Oct 1;187:110-122. doi: 10.1016/j.actbio.2024.08.022. Epub 2024 Aug 22.
Decellularised extracellular matrix (dECM) produced by mesenchymal stromal cells (MSCs) is a promising biomaterial for improving the ex vivo expansion of MSCs. The dECMs are often deposited on high modulus surfaces such as tissue culture plastic or glass, and subsequent differentiation assays often bias towards osteogenesis. We tested the hypothesis that dECM deposited on substrates of varying modulus will produce cell culture environments that are tailored to promote the proliferation and/or lineage-specific differentiation of MSCs. dECM was produced on type I collagen-functionalised polyacrylamide hydrogels with discrete moduli (∼4, 10, and 40 kPa) or in a linear gradient of modulus that spans the same range, and the substrates were used as culture surfaces for MSCs. Fluorescence spectroscopy and mass spectrometry characterization revealed structural compositional changes in the dECM as a function of substrate modulus. Softer substrates (4 kPa) with dECM supported the largest number of MSCs after 7 days (∼1.6-fold increase compared to glass). Additionally, osteogenic differentiation was greatest on high modulus substrates (40 kPa and glass) with dECM. Nuclear translocation of YAP1 was observed on all surfaces with a modulus of 10 kPa or greater and may be a driver for the increased osteogenesis on the high modulus surfaces. These data demonstrate that dECM technology can be integrated with environmental parameters such as substrate modulus to improve/tailor MSC proliferation and differentiation during ex vivo culture. These results have potential impact in the improved expansion of MSCs for tailored therapeutic applications and in the development of advanced tissue engineering scaffolds. STATEMENT OF SIGNIFICANCE: Mesenchymal stromal cells (MSCs) are extensively used in tissue engineering and regenerative medicine due to their ability to proliferate, differentiate, and modulate the immune environment. Controlling MSC behavior is critical for advances in the field. Decellularised extracellular matrix (dECM) can maintain MSC properties in culture, increase their proliferation rate and capacity, and enhance their stimulated differentiation. Substrate stiffness is another key driver of cell function, and previous reports have primarily looked at dECM deposition and function on stiff substrates such as glass. Herein, we produce dECM on substrates of varying stiffness to create tailored environments that enhance desired MSC properties such as proliferation and differentiation. Additionally, we complete mechanistic studies including quantitative mass spec of the ECM to understand the biological function.
去细胞细胞外基质(dECM)由间充质基质细胞(MSCs)产生,是一种很有前途的生物材料,可用于改善 MSC 的体外扩增。dECM 通常沉积在高模量表面上,例如组织培养塑料或玻璃,随后的分化测定通常偏向成骨。我们测试了这样一种假设,即沉积在不同模量基底上的 dECM 将产生针对细胞培养环境的定制,以促进 MSC 的增殖和/或谱系特异性分化。dECM 是在具有离散模量(约 4、10 和 40 kPa)的 I 型胶原蛋白功能化聚丙烯酰胺水凝胶上产生的,或者在横跨相同范围的模量线性梯度上产生,并且这些基质用作 MSC 的培养表面。荧光光谱和质谱分析揭示了 dECM 作为基底模量函数的结构组成变化。较软的基底(4 kPa)上的 dECM 在 7 天后支持最多数量的 MSC(与玻璃相比增加了约 1.6 倍)。此外,在高模量基底(40 kPa 和玻璃)上的 dECM 支持最大的成骨分化。在模量为 10 kPa 或更高的所有表面上都观察到 YAP1 的核易位,并且可能是高模量表面上成骨增加的驱动因素。这些数据表明,dECM 技术可以与环境参数(如基底模量)集成在一起,以改善/定制 MSC 增殖和分化。这些结果对于改进用于定制治疗应用的 MSC 的体外扩增以及先进的组织工程支架的开发具有潜在的影响。
间充质基质细胞(MSCs)由于其增殖、分化和调节免疫环境的能力,被广泛用于组织工程和再生医学。控制 MSC 行为对于该领域的发展至关重要。去细胞细胞外基质(dECM)可以在培养中维持 MSC 的特性,增加其增殖率和容量,并增强其刺激分化。基底刚度是细胞功能的另一个关键驱动因素,先前的报告主要研究了 dECM 在硬基底(如玻璃)上的沉积和功能。在此,我们在不同刚度的基底上产生 dECM,以创建定制的环境,从而增强 MSC 的增殖和分化等所需特性。此外,我们完成了包括 ECM 定量质量谱的机制研究,以了解生物学功能。